⌘K

Login Start Free

Home/Filings/4/0001562180-18-004189

4//SEC Filing

Strum Jay 4

Accession 0001562180-18-004189

CIK 0001560241other

View on SEC.gov Company Profile

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 6:04 PM ET

Size

10.4 KB

Accession

0001562180-18-004189

Insider Transaction Report

Form 4

Period: 2018-10-04

G1 Therapeutics, Inc.GTHX

Chief Scientific Officer

Transactions

Exercise/Conversion
Stock Options (Right to Buy)
2018-10-04−850→ 15,816 total
Exercise: $0.30Exp: 2022-11-09→ Common Stock (850 underlying)
Exercise/Conversion
Common Stock
2018-10-04$0.30/sh+850$255→ 49,419 total

Footnotes (1)

[F1]All shares underlying this option have vested.

Documents

2 files

Issuer

G1 Therapeutics, Inc.

CIK 0001560241

Entity typeother

Related Parties

1

filerCIK 0001706851

Filing Metadata

Form type: 4
Filed: Oct 4, 8:00 PM ET
Accepted: Oct 5, 6:04 PM ET
Size: 10.4 KB

View on SEC.gov